. Author manuscript; available in PMC: 2021 Dec 1.

Published in final edited form as: J Surg Oncol. 2020 Sep 6;122(8):1778–1784. doi: 10.1002/jso.26200

TABLE 4.

Multivariate logistic regression for odds of positive completion lymph node dissection

	Odds ratio	95% Confidence interval	P value
Before MSLT-II implementation^a	0.72	0.182–2.85	.639
BMI >30	2.56	0.678–9.75	.167
Location, head and neck	0.33	0.060–1.80	.197
≥3 positive lymph nodes at SLNB	12.04	1.67–83.5	.013
Sentinel lymph node tumor burden > 1 mm^b	25.71	2.54–231	.005

Abbreviations: BMI, body mass index; CLND, completion lymph node dissection; SLNB, sentinel lymph node biopsy.

The inflection point for implementation is based on an observation of trends in CLND by quarter after MSLT-II publication, Figure 1.

No CLND was positive for patients with sentinel node tumor burden < 0.1 mm.